» Articles » PMID: 16018986

Alcohol Dependence is Associated with Blunted Dopamine Transmission in the Ventral Striatum

Overview
Journal Biol Psychiatry
Publisher Elsevier
Specialty Psychiatry
Date 2005 Jul 16
PMID 16018986
Citations 202
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A decrease in dopamine type 2 receptors (D2) and mesolimbic dopamine transmission predisposes animals to consume alcohol. This study measured D2 receptors and dopamine transmission in human alcohol-dependent (AD) subjects using positron emission tomography (PET) and [11C]raclopride.

Methods: Fifteen AD and 15 healthy control (HC) subjects were scanned before and after a psychostimulant challenge (amphetamine .3 mg/kg intravenous). The outcome measures for baseline D2 receptor availability were binding potential (BP) and the equilibrium partition coefficient (V3''). Amphetamine-induced [11C]raclopride displacement was measured as the difference in V3'' between the two scans.

Results: [11C]raclopride BP was significantly reduced by 16.6% in the limbic striatum, 19.2% in the associative striatum, and 21.3% in the sensorimotor striatum in AD subjects compared with HC. The alcohol-dependent subjects showed a blunting of amphetamine-induced dopamine release in the limbic striatum: [11C]raclopride displacement was -5.2% +/- 3.6% in AD subjects compared with -13.0% +/- 8.8% in HC. However, no significant difference in [11C]raclopride displacement was seen in the associative (-4.6% +/- 5.8% in AD subjects vs. -6.7 +/- 5.4% in HC) and sensorimotor (-12.3% +/- 7.3% in AD subjects vs. -13.7 +/- 7.5% in HC) subdivisions of the striatum between the two groups.

Conclusions: Alcohol dependence was associated with a decrease in D2 receptors in each striatal subdivision, whereas amphetamine-induced dopamine release was reduced in the limbic striatum only.

Citing Articles

Synchrony between midbrain gene transcription and dopamine terminal regulation is modulated by chronic alcohol drinking.

Farahbakhsh Z, Holleran K, Sens J, Fordahl S, Mauterer M, Lopez A Nat Commun. 2025; 16(1):1944.

PMID: 39994195 PMC: 11850823. DOI: 10.1038/s41467-025-56715-y.


Effects of GLP-1 Receptor Agonists in Alcohol Use Disorder.

Klausen M, Knudsen G, Vilsboll T, Fink-Jensen A Basic Clin Pharmacol Toxicol. 2025; 136(3):e70004.

PMID: 39891507 PMC: 11786240. DOI: 10.1111/bcpt.70004.


Intra-striatal dopaminergic inter-subject covariance in social drinkers and non-treatment-seeking alcohol use disorder participants.

Chumin E, Dzemidzic M, Yoder K Addict Biol. 2024; 29(11):e70008.

PMID: 39576234 PMC: 11583815. DOI: 10.1111/adb.70008.


Vitamin D's Capacity to Increase Amphetamine-Induced Dopamine Release in Healthy Humans: A Clinical Translational [C]-PHNO Positron Emission Tomography Study.

Worhunsky P, Mignosa M, Gallezot J, Pittman B, Nabulsi N, Stryjewski A Biol Psychiatry. 2024; 97(6):651-658.

PMID: 39395473 PMC: 11839384. DOI: 10.1016/j.biopsych.2024.09.028.


Association of Neuromelanin-Sensitive MRI Signal With Lifetime Substance Use in Young Women.

Perlman G, Wengler K, Moeller S, Kotov R, Klein D, Weinstein J Am J Psychiatry. 2024; 181(11):997-1005.

PMID: 39380373 PMC: 11637462. DOI: 10.1176/appi.ajp.20220819.